drugset / Trial / NCT04500470

Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography

NCT04500470

Completed 200 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of our study is to determine the efficacy of Ketoprofen with or without vaginal isonicotinic acid hydrazide on the pain scores during HSG.

Timeline

Start
2020-09-01
Primary completion
2021-07-30
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Isonicotinic Acid Hydrazide Unknown 900 mg Other
Background Ketoprofen Small molecule Oral

Indications